This Government Contract opportunity from Department Of Health And Human Services was posted on May 18, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
Intent to Sole Source - Reagents and Consumables required for Systemic Autoimmune Rheumatic Diseases.
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The National Institutes of Health (NIH), specifically the Office of Purchasing and Contracts acting for the Critical Care Medicine Department, plans to enter into a firm-fixed price contract with 10X Genomics, Inc. for the procurement of reagents and consumables necessary for research or treatment related to Systemic Autoimmune Rheumatic Diseases. This acquisition will be conducted on a sole-source basis under the authority of 41 U.S.C. 253(c)(1) and FAR 6.302-1, citing that only one responsible vendor is capable of fulfilling the agency’s unique requirements, thus not opening this opportunity to full and open competition. Although this notice is not a request for proposals, interested and capable vendors are invited to submit capability statements for consideration by June 2, 2026, though the decision to compete or proceed with the sole source award remains at the government’s sole discretion. The contract is identified under solicitation number NOI-CC-OLAO-26-006103 and is aimed at acquiring highly specialized materials critical to NIH's work in autoimmune diseases, with performance and administration centered in Bethesda, Maryland. No set-aside designations apply to this acquisition.
General Info
Agency
NAICS
Place of Performance
Bethesda, MD, 20892, USASet-Aside
Timeline
Submission Closed
Organization & Contact Information
Full Description
This is a Notice of Intent, not a request for proposal. The National Institute of Health intends to negotiate on an other than full and open competition basis with the following vendor: 10X Genomics, Inc.
Acquisition Description:
The National Institutes of Health, Office of Purchasing and Contracts on behalf of the Critical Care Medicine Department intends to award a firm-fixed priced contract to 10X Genomics Inc. for the acquisition of reagents and consumables required for Systemic Autoimmune Rheumatic Diseases.
The statutory authority for this sole source requirement is 41 U.S.C. 253(c) (1) as implemented by FAR 6.302-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL. All responsible sources that could provide the required may submit a capability statement that will be considered by email (subject line to reference NOI-CC-OLAO-26-006103) by 12:00 PM eastern standard time on 06/02/2026 to: valerie.gregorio@nih.gov.
All responses received by the closing date of this synopsis will be considered by the Government. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.
